Legacy Citation Support
21 U.S.C. § 353a-1
This citation is not available as a current section page in the published edition on this site, but the citation remains a meaningful historical or legacy reference.
Use the current title page and nearby sections below to continue browsing Title 21. When old citations remain in crawlers, briefs, or legacy links, this page preserves the citation locally instead of sending users to a dead end.
Nearby current sections
- § 351 — Adulterated drugs and devices
- § 352 — Misbranded drugs and devices
- § 353 — Exemptions and consideration for certain drugs, devices, and biological products
- § 353a — Pharmacy compounding
- § 353a–1 — Enhanced communication
- § 353b — Outsourcing facilities
- § 353c — Prereview of television advertisements
- § 353d — Process to update labeling for certain generic drugs